Archives for March 9, 2010

← 2010

Wacker opens €18m expansion of biologics site

By Nick Taylor

Wacker Chemie AG has expanded its biologics production facility, adding GMP manufacturing capacity and a process development building in response to customer demand.

Electronic submission offers benefits for pharma, says ISI

By Gareth Macdonald

Drug firms continue to make basic errors in their electronic submissions according to French regulatory group the AFSSAPS, which said recently that it returns half the NeeS dossiers it receives as they do not meet basic validation standards.

Wuxi income up in ’09, plans investments this year

By Nick Taylor

WuXi PharmaTech posted an operating profit of $52m (€38m) in 2009 and is optimistic about 2010, when it will make investments in laboratory services and large-scale manufacturing to drive growth in coming years.